St. Louis, MO, United States of America

Pepex Biomedical, Inc.


USPTO Granted Patents = 20

% Expired Patents = 55.0


Forward Citations = 1,632

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal James L Say (19 out of 121 patents)

silverMedal Henning Sakslund (2 out of 4 patents)

bronzeMedal Eric A Peper (2 out of 2 patents)

4.  Nathan R Long (2 out of 2 patents)

5.  Vojtech Svoboda (1 out of 12 patents)

6.  Stephen L Pohl (1 out of 3 patents)

7.  Michael F Tomasco (1 out of 97 patents)

8.  Mark S Vreeke (1 out of 92 patents)

9.  James I Say (1 out of 1 patent)

10.  Steve Pohl (0 patent)

11.  Steve L Pohl (0 patent)


20 patents:

Company Overview
Pepex Biomedical, Inc. is a St. Louis-based company specializing in the development of innovative medical devices aimed at enhancing patient care. The organization focuses on advanced technologies that address critical needs in the healthcare sector, particularly in the areas of wound care and tissue regeneration. By leveraging cutting-edge research and engineering, Pepex Biomedical strives to deliver effective solutions that improve clinical outcomes and support healthcare professionals in their efforts to provide high-quality patient treatment.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

20 Patents

#107 in St. Louis, MO

#233 in Missouri

#16,382 in US

#31,233 in the World

St. Louis, MO (US)
St. Louis, MO, United States of America
Forward Citations = 1,632

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pepex Biomedical, Inc.. Retrieved from https://idiyas.com/company/pepex-biomedical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…